Drug Pipeline Updates
In this section you will find Publication Series Analytical Tool Drug Pipeline Updates market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
Ovarian Cancer Drug Pipeline Update 2011
€1,499.00Published by BioSeeker Group on Feb 1st, 2011There are today 216 (203) companies plus partners developing 286 (263) drugs targeting ovarian cancer in active development. In addition, the accumulated number of ceased drugs over the last years amount to another 74 (71) drugs. Ovarian Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 195 (175) different targets. Learn More -
IL-6 Signaling Pathway in Oncology Drug Pipeline Update 2011
€1,499.00Published by BioSeeker Group on Feb 1st, 2011There are today 218 companies plus partners developing 292 IL-6 pathway targeting drugs in 777 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 114 drugs. Il-6 Signaling Pathway In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 119 different targets. Learn More -
EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2011
€1,499.00Published by BioSeeker Group on Feb 1st, 2011There are today 175 companies plus partners developing 241 EGFR1 pathway targeting drugs in 797 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 96 drugs. Egfr1 Signaling Pathway In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 124 different targets. Learn More -
Bladder Cancer Drug Pipeline Update 2011
€999.00Published by BioSeeker Group on Feb 1st, 2011There are today 93 (81) companies plus partners developing 104 (86) drugs targeting bladder cancer in active development. In addition, the accumulated number of ceased drugs over the last years amount to another 28 (25) drugs. Bladder Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 72 (57) different targets. Learn More -
IL-4 Signaling Pathway in Oncology Drug Pipeline Update 2011
€1,499.00Published by BioSeeker Group on Feb 1st, 2011There are today 128 companies plus partners developing 163 IL-4 pathway targeting drugs in 432 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 61 drugs. Il-4 Signaling Pathway In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 94 different targets. Learn More -
Proteins in Oncology Drug Pipeline Update 2011
€1,499.00Published by BioSeeker Group on Feb 1st, 2011There are today 311 companies plus partners developing 338 protein drugs in 571 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 152 drugs. Proteins In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 154 different targets. Learn More -
Prostate Cancer Drug Pipeline Update 2011
€1,499.00Published by BioSeeker Group on Feb 1st, 2011There are today 327 (294) companies plus partners developing 396 (354) drugs targeting prostate cancer in active development. In addition, the accumulated number of ceased drugs over the last years amount to another 162 (148) drugs. Prostate Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 226 (202) different targets. Learn More -
IL-2 Signaling Pathway in Oncology Drug Pipeline Update 2011
€1,499.00Published by BioSeeker Group on Feb 1st, 2011There are today 185 companies plus partners developing 258 IL-2 pathway targeting drugs in 746 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 86 drugs. Il-2 Signaling Pathway In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 116 different targets. Learn More -
Cellular Therapy in Oncology Drug Pipeline Update 2011
€999.00Published by BioSeeker Group on Feb 1st, 2011There are today 69 (43) companies plus partners developing 55 (37) cellular therapy drugs in 102 (58) developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 62 (36) drugs. Cellular Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 20 (16) different targets. Learn More -
Hematological Cancers Drug Pipeline Update 2011
€1,999.00Published by BioSeeker Group on Feb 1st, 2011There are today 377 (324) companies plus partners developing 594 (476) hematological cancer drugs in 1091 (869) developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 178 (148) drugs. Hematological Cancers Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 293 (258) different targets. Learn More -
T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2011
€1,499.00Published by BioSeeker Group on Feb 1st, 2011There are today 152 companies plus partners developing 170 T cell receptor pathway targeting drugs in 507 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 82 drugs. T Cell Receptor Signaling Pathway In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 81 different targets. Learn More -
Cytokine Therapy in Oncology Drug Pipeline Update 2011
€999.00Published by BioSeeker Group on Feb 1st, 2011There are today 83 (69) companies plus partners developing 104 (70) cytokine drugs in 205 (139) developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 6 (5) drugs. Cytokine Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 20 (19) different targets. Learn More -
Immunotherapy in Oncology Drug Pipeline Update 2011
€2,450.00Published by BioSeeker Group on Feb 1st, 2011There are today 473 (421) companies plus partners developing 978 (783) cancer immunotherapy drugs in 1959 (1573) developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 333 (334) drugs. Immunotherapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 336 (315) different targets. Learn More -
Kit Receptor Signaling Pathway in Oncology Drug Pipeline Update 2011
€1,499.00Published by BioSeeker Group on Feb 1st, 2011There are today 129 companies plus partners developing 156 Kit receptor pathway targeting drugs in 569 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 67 drugs. Kit Receptor Signaling Pathway In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 94 different targets. Learn More -
Radiation Therapy in Oncology Drug Pipeline Update 2011
€1,499.00Published by BioSeeker Group on Feb 1st, 2011There are today 322 (259) companies plus partners developing 326 (227) radiation therapy drugs in 677 (497) developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 121 (84) drugs. Radiation Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 172 (145) different targets. Learn More